Biobanks are promising instruments of biomedical research and of transnational medicine in particular. Ethical, legal and social issues associated with biobanking, however, have recently led to a more critical view on this concept. All efforts addressing these concerns have been grounded on well-established standards of biomedical ethics such as informed consent procedures, protection of individual autonomy, benefit sharing etc. By additionally highlighting the widely neglected aspect of trust, this book aims at broadening the horizon of the ELSI-debate and thus filling a gap in current research on biobanking. The contributions of leading experts and junior researchers cover a wide field of disciplines relevant for biobanking including law, ethics, medicine, public health, social sciences, philosophy and theology.

​Dieses Open-Access-essential schafft Orientierung, wenn Künstliche Intelligenz im klinischen Alltag eingesetzt wird. Die Herausforderungen werden anhand zweier Beispiele aus dem Bereich der Nephrologie erläutert, die ethisch und rechtlich reflektiert werden. Ein umfangreicher Empfehlungsteil schließt diesen durchweg interdisziplinär erarbeiteten Band ab.

The book considers the relationship between governance and participation, and the ways participation has been understood, framed and applied in the context of synthetic biology (SB) governance approaches. Based on fundamental questions about the scope, purpose, and responsibilities assigned to public participation activities, the authors conducted an literature review of policy reports and articles on SB governance. The authors identify key characteristics of synthetic biology, such as the complex interplay of research, engineering and IT expertise in the field, as well as the challenges these characteristics pose in designing governance frameworks. Drawing on insights from a literature review, the authors contest calls for "earlier" and "more" participation on the basis that such calls fail to consider the necessary structural adjustments and resources needed for such endeavors. The brief addresses ethical questions arising in synthetic biology that could be used for developing frameworks of governance in the ongoing COVID-19 crisis and the consequent innovations in vaccine research.

Genome Editing Techniques are seen to be at the frontier of current research in the field of emerging biotechnologies. The latest revolutionary development, the so-called CRISPR technology, represents a paradigmatic example of the ambiguity of such techniques and has resulted in an international interdisciplinary debate on whether or not it is necessary to ban the application of this technique by means of a moratorium on its use for human germline modifications, particularly in human embryos in the reproduction process. However, given that other germline engineering techniques like mitochondrial (mt) DNA transfer techniques are already permitted and applied, the question arises what lies at the root of the apparent social unease about the modification of the human germline by Genome Editing Techniques like CRISPR. Against this background, the book seeks to make a substantial contribution to the current debate about a responsible and participatory framework for research on emerging biotechnologies by analysing underlying perceptions, attitudes, arguments and the reasoning on Genome Editing Techniques.

In diesem Open-Access-Buch untersuchen wir, was Datensouveranitat aus ethischer und rechtlicher Perspektive bedeuten kann und entwickeln mittels des Modells der dynamischen Einwilligung konkrete Governance-Ansatze fur den Gesundheitsbereich. Im Zeitalter der Digitalisierung stellt uns der verantwortungsvolle Umgang mit Daten vor eine Herausforderung: Moegliche Fortschritte in Forschung, Versorgung und oeffentlicher Gesundheit rufen Fragen von Datenschutz und Kontrollanspruchen auf. Ein normatives Leitkonzept, das in den vergangenen Jahren beim Umgang mit Daten in den Vordergrund tritt, ist Datensouveranitat.